Last edition
News about Quality / GMP
LGM Pharma Expands Analytical Testing Services with New Services
These new services, now available at LGM Pharma’s Irvine, CA, facility, offer significant benefits to drug developers, including accelerated turnaround times, enhanced quality control, and cost savings.
Quality / GMP | 16/10/2024 | By Aishwarya
Avery Dennison Rolls Out AD Minidose U9XM to Ensure Authenticity of Pharma Devices
The NXP U9XM chip offers a self-adjust feature to maximize product performance. It provides high read reliability and enhanced performance, even when small tagged items are densely packed in close proximity.
Quality / GMP | 28/08/2024 | By Aishwarya | 108
The 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond.
Quality / GMP | 18/10/2023 | By Manvi | 470
Gritgen Therapeutics Launches Operations at Commercial GMP Facility in China
The facility adheres to the global cGMP standards and complies with the regulatory guidelines of authoritative agencies including the NMPA, the FDA and the EMA.
Quality / GMP | 16/10/2023 | By Manvi | 357
Aurisco's Manufacturing Site in China Clears FDA Inspection
Aurisco's Manufacturing Site in China Clears FDA Inspection
Quality / GMP | 24/08/2023 | By Sudeep Soparkar | 375
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)
Quality / GMP | 23/08/2023 | By Sudeep Soparkar | 311
Quality / GMP | 23/08/2023 | By Sudeep Soparkar | 537
Successful FDA inspection at Auriscos manufacturing site in Yangzhou, China
Successful FDA inspection at Aurisco's manufacturing site in Yangzhou, China
Quality / GMP | 16/08/2023 | By Sudeep Soparkar | 472
Lupins Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Quality / GMP | 14/08/2023 | By Sudeep Soparkar | 427
Dr. Reddys API plant in Hyderabad gets EIR from U.S. FDA
Dr. Reddy’s API plant in Hyderabad gets EIR from U.S. FDA
Quality / GMP | 08/08/2023 | By Sudeep Soparkar | 793
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy